Results
|
|
1181.
|
Randomized phase II trial of irinotecan and bevacizumab as neo-adjuvant and adjuvant to temozolomide-based chemoradiation compared with temozolomide-chemoradiation for unresectable glioblastoma: final results of the TEMAVIR study from ANOCEF†. [electronic resource] by
- Chauffert, B
- Feuvret, L
- Bonnetain, F
- Taillandier, L
- Frappaz, D
- Taillia, H
- Schott, R
- Honnorat, J
- Fabbro, M
- Tennevet, I
- Ghiringhelli, F
- Guillamo, J S
- Durando, X
- Castera, D
- Frenay, M
- Campello, C
- Dalban, C
- Skrzypski, J
- Chinot, O
Producer: 20150831
In:
Annals of oncology : official journal of the European Society for Medical Oncology vol. 25
Availability: No items available.
|
|
|
1182.
|
|
|
|
1183.
|
|
|
|
1184.
|
|
|
|
1185.
|
|
|
|
1186.
|
|
|
|
1187.
|
|
|
|
1188.
|
|
|
|
1189.
|
|
|
|
1190.
|
|
|
|
1191.
|
|
|
|
1192.
|
|
|
|
1193.
|
|
|
|
1194.
|
|
|
|
1195.
|
|
|
|
1196.
|
|
|
|
1197.
|
|
|
|
1198.
|
|
|
|
1199.
|
|
|
|
1200.
|
|